Does low total IgM rule out a positive antigen-specific IgM?

Low total IgM and a positive antigen-specific IgM result are not inherently contradictory. In an 83-year-old man, interpretation should be driven primarily by the clinical syndrome, timing, exposure risk, and validated testing rather than by either laboratory finding alone.

Humoral-response implications

• Low total IgM is plausibly a marker of impaired or narrower primary antibody responsiveness, particularly with broader B-cell dysfunction or prior B-cell-depleting therapy. Low IgM has tracked poorer influenza and SARS-CoV-2 vaccine serologic responses in rituximab-treated cohorts.
• It does not, however, establish impaired antigen-specific function. In selective IgM deficiency, many people retain surface-IgM-positive B cells and responses to protein or polysaccharide antigens. In a 57-patient cohort, 47% had impaired pneumococcal responses, but this did not correlate with serum IgM concentration.

Meaning of positive Borrelia-specific IgM

• Detectable Borrelia-specific IgM remains biologically plausible despite low total IgM; serum concentration alone does not predict whether antigen-specific antibodies can be made.
• A positive result is not proof of current infection. IgM assays are vulnerable to nonspecific and cross-reactive antibodies from other infections or autoimmune disease, and Borrelia IgM can persist after resolved infection.
• In clinical cohorts, 53% of reported positive IgM immunoblots were judged false positive, mainly isolated-IgM/negative-IgG findings with symptoms beyond four weeks; another laboratory cohort estimated a 25.5% false-positive rate for isolated IgM immunoblots.

Clinical interpretation

• Use validated two-tier testing. CDC guidance limits meaningful diagnostic use of IgM to symptoms of ≤30 days; after this, isolated IgM should be disregarded in favor of IgG interpretation.
• With recent, compatible illness and credible exposure, IgM can be supportive evidence. If suspicion remains in an untreated patient, repeat testing in 7–14 days for IgG seroconversion.

Bottom line

• Low total IgM neither validates nor invalidates a positive antigen-specific IgM. The discordant pattern warrants cautious, time-anchored clinical interpretation—not a diagnosis of active infection by itself.